Brief: PCI Biotech Q2 Operating Loss Narrows To NOK 19.1 Mln
Aug 31 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* REG-PCI BIOTECH FIRST HALF-YEAR 2021 INTERIM RESULTS
* Q2 OPERATING LOSS NOK 19.1 MILLION VERSUS LOSS NOK 22.3
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE1WV1HD
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process